Guidance Archives - Page 42 of 637

2 minute read

Generic Drugmaker Amneal Announces Over $270M In US Opioid Lawsuit Settlement

May 3, 2:43 PM

Amneal Pharmaceuticals settles $270 million opioid crisis agreement, offering cash and naloxone spray. Boosted by strong Q1 earnings, the company reaffirms fiscal guidance.

AMRX

2 minute read

Frontier’s CEO Celebrates Turnaround With Revenue Growth and Customer Base Expansion

By Anusuya Lahiri

May 3, 1:55 PM

Frontier Communications Parent, Inc reported a 1.5% revenue growth and EPS beat in Q1 2024. Fiber products drove revenue while copper-based products declined.

FYBR

1 minute read

What’s Going On With Healthcare Logistics Giant Owens & Stock On Friday?

By Vandana Singh

May 3, 12:56 PM

Owens & Minor impresses with Q1 results: adjusted EPS of $0.19, and sales of $2.61B (up 4% Y/Y). Patient Direct revenue reaches $638M (up 5% Y/Y). CEO Edward Pesicka highlights growth strategies and reaffirms 2024 revenue guidance of $10.5-$10.9 billion and adjusted EPS of $1.40-$1.70.

OMI

1 minute read

Why Is Automotive Seating Company Adient Stock Falling After Q2 Earnings?

By Nabaparna Bhattacharya

May 3, 12:47 PM

Adient Plc shares dip post-Q2 earnings, despite beating adjusted EPS but missing sales estimates, as it lowers FY24 outlook.

ADNT

1 minute read

Advanced Manufacturing and Factory Automation Company Trimble Stock Slides After Q1 Print, What’s Going On?

By Anusuya Lahiri

May 3, 12:05 PM

Trimble Inc reported Q1 2024 revenue growth of 4% to $953.30M, beating consensus. Adjusted EPS of $0.64 also beat consensus. Stock price rose after results.

IVEG

2 minute read

Amgen Outlook Is Bright, Analyst Predict Obesity-Focused Drug Potential Will Drive Shareholder Value

By Vandana Singh

May 3, 11:24 AM

Amgen earnings beat estimates, and MariTide's promising Phase 2 results suggest significant differentiation from competitors.

AMGN

2 minute read

Pipeline Powerhouse Plains All American Beats On Earnings with Flat EBITDA: Details

By Lekha Gupta

May 3, 11:07 AM

PAA reported higher revenue of $11.995B, missing consensus. Operating income and adjusted EBITDA were flat. Company expects flat EBITDA in 2026.

AMLP

1 minute read

Why Is Engineering Company Fluor’s Stock Falling Today?

By Akanksha Bakshi

May 3, 10:39 AM

Fluor reported a Q1 FY2024 revenue decline of 0.5%, missing consensus. Sales by segment: Energy, Urban, Mission, and Others. Adjusted EPS at $0.47. Total new awards of $7.02B. 2024 outlook reaffirmed.

FLR

1 minute read

Why Restaurant Chain El Pollo Loco’s Shares Are Soaring Today

By Shivani Kumaresan

May 3, 10:15 AM

El Pollo Loco Holdings showcases robust growth, reporting a 1.4% year-on-year sales increase to $116.15 million in first-quarter FY24, surpassing analyst expectations. With a 5.1% rise in system-wide comparable restaurant sales and a 24% surge in operating income to $9.7 million, the company demonstrates resilience and profitability in its performance.

LOCO

2 minute read

FuboTV Gaining Popularity North America, High Growth In Paid Subscribers Show

By Anusuya Lahiri

May 3, 10:10 AM

FuboTV (NYSE: FUBO) reported strong Q124 results with sales up 24%, beating estimates. North America revenue up 24%, paid subscribers up 18%, and ARPU up 10%. Lawsuit against DIS, FOX, WBD remains. Q2 and FY24 revenue outlook revised upwards. FUBO stock up 11% at $1.72 premarket.

DIS